ArticleThe Lancet regional health. Europe2022

Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK).

Giulia Vivaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.